Bio Protocol Unveils Biofy: Turning Decentralized Science Into Real Products

Bio Protocol unveiled Biofy, a new platform designed to turn decentralized scientific research into real, purchasable products. Biofy acts as a commerce and logistics layer for Decentralized Science, often called DeSci. In simple terms, it connects open research communities directly to consumers, allowing science-backed products to be validated, produced, and shipped without relying on traditional institutions.

What Problem is Biofy Trying to Solve?

For decades, advanced biology and health research have moved slowly from lab to consumer. Research is often locked inside universities, pharmaceutical firms, or private labs. Results take years to validate, are hard to verify, and rarely connect directly to everyday health decisions.

At the same time, consumers face a crowded health product market filled with unclear claims, limited sourcing information, and little accountability. Even well-intentioned products often lack transparent links to the research behind them.

Biofy is designed to address both sides of this problem.

It gives DeSci organizations a way to bring research into the real world while giving consumers clear insight into where products come from, how they were tested, and who helped shape them.

What is Biofy and How Does it Work?

Biofy is described as a “Shopify for science-backed products,” but its role goes beyond simple online storefronts. It is a system that links research, validation, commerce, and feedback into one loop.

At a basic level, Biofy allows research organizations within the Bio Network to launch products directly to consumers. These products are tied to open research, lab testing, and community review.

Each product on Biofy traces back to:

• The research that inspired it
• The labs involved in testing
• The community that helped fund, review, or refine it

This creates visible provenance, meaning users can see where claims come from rather than trusting marketing labels.

From Open Science to Lived Biology

Bio Protocol frames Biofy as a move from “open science” to “lived biology.” According to the protocol, research should not remain abstract or locked in papers. It should be tested, used, and refined through real-world feedback.

Biofy supports this by combining:

• Self-experimentation, where users track how products affect them
• Scientific validation through labs and data
• Community feedback that informs future versions.

How Does Biofy Fit into the Bio Protocol Ecosystem?

Biofy is one part of a broader system built by Bio Protocol. The platform operates across three connected layers.

• Bio Protocol functions as the launchpad. It helps DeSci organizations raise funds, form communities, and move ideas from lab concepts toward real applications.

• BioAgents provide the intelligence layer. These are AI-driven co-scientists that analyze research outputs, usage data, and community input to surface insights such as what works, for whom, and why.

• Biofy is the distribution layer. It turns those insights into products that can be manufactured, shipped, and improved in near real time.

Together, these layers form a closed loop where research learns directly from real-world use.

Early Examples

Biofy is not launching into a vacuum. Early signs of this model already exist within the Bio Network.

HairDAO has developed community-driven hair loss treatments, shaped by open research and user feedback.

CerebrumDAO has worked on brain health formulations using a similar approach.

Biofy aims to connect these efforts into a unified system that supports global distribution, cross-border payments, and transparent validation.

Why DeSci organizations are adopting a barbell model

DeSci groups working with Bio Protocol often follow what is described as a “barbell” approach.

On one side are consumer-facing products. These generate revenue, build communities, and produce real-world data.

On the other side is longer-term research, such as drug discovery and advanced biotechnology, which takes more time and capital.

Organizations like HairDAO, CerebrumDAO, and VitaDAO already operate this way. They sell products to early adopters while reinvesting profits and data into deeper research.

This structure helps research groups survive without relying entirely on grants or venture funding.

How Rewards and Community Ownership Work

Biofy introduces a reward system that differs from traditional health brands.

Instead of being passive customers, users can earn BioXP by participating in product launches and feedback.

The process works as follows:

• New products launch on a pre-order basis
• Early buyers earn BioXP
• BioXP grants access to token sales and incentives from the originating DeSci organization
• Users who review products or join decentralized trials can earn additional tokens

This model gives users a stake in product development rather than treating them as end buyers only. It also creates stronger alignment between researchers, product teams, and communities.

What Products are Launching First on Biofy?

The first live product on Biofy is DermaLabs Moon + Sol Drops, available for pre-order.

Buyers earn BioXP that can later be used in token sales on the Bio Protocol, including DermaLabs’ upcoming $SKIN token sale.

Bio Protocol has stated that BioXP rewards per bottle will decrease after the first 300 bottles are sold. This links early participation with higher rewards.

More products from other DeSci organizations are expected to follow.

Bio Protocol Expands on BNB Chain

Bio Protocol recently confirmed that its BIO token is now live for trading on BNB Chain.

Users can swap BIO on PancakeSwap and interact with Bio Protocol’s tools through BNB Chain’s infrastructure. This move expands Bio Protocol’s reach across major blockchain ecosystems.

The BNB Chain version of BIO uses the same contract logic as the original asset. Additional Bio tokens are expected to be bridged over in the coming weeks.

Bio Protocol shared the BNB Chain contract address publicly to support transparency and verification.

The BIO token plays a central role in Bio Protocol’s system.

It supports:

• Onchain coordination for research projects
• Access to AI models and BioAgents
• Staking mechanisms tied to DeSci workflows
• Participation in launches and governance

Background on Bio Protocol funding

Last September, Bio Protocol raised $6.9 million in a funding round anchored by Maelstrom Fund. Other participants included Mechanism Capital, Animoca Brands, Presto Labs, and biotech-focused investors.

The funding supports Bio Protocol’s expansion into a full-stack DeSci platform that combines:

• AI-driven research tools
• Decentralized funding systems
• Drug discovery pipelines
• Onchain attribution and data integrity

The goal is to reduce fragmentation in research coordination and give independent researchers access to tools typically locked inside large institutions.

What are BioAgents and Why Do They Matter?

At the core of Bio Protocol are BioAgents, which act as autonomous AI co-scientists.

BioAgents are designed to:

• Generate research hypotheses
• Manage onchain wallets
• Fund experiments automatically
• Record research steps onchain

The first BioAgent, Aubrai, launched in August 2025 in collaboration with VitaDAO and longevity researcher Dr. Aubrey de Grey.

In its first weeks, Aubrai:

• Raised over $900,000 in research funding
• Minted more than 1,000 hypotheses onchain
• Enabled immediate testing through agent-managed workflows

Bio Protocol plans to expand this system globally, allowing networks of BioAgents to work alongside human researchers.

Conclusion

Bio Protocol’s unveiling of Biofy shows how decentralized science reaches the real world. Biofy provides a commerce and logistics layer that connects open research, AI-driven analysis, and community feedback to real products.

Combined with BioAgents and the BIO token, Biofy completes a system where research, funding, and distribution reinforce each other. The result is a platform that focuses on traceability, validation, and real-world use, rather than promises or marketing claims.

Resources

1. Bio Protocol on X: Announcement (Dec. 22, 2025)

2. Biofy website: General info

3. Post on Biofy unveiling: About Biofy

4. Bio Protocol announcement: Bio Protocol Raises $6.9M to Launch AI-Native Decentralized Science Platform for Biotech Funding & Drug Discovery

5. Bio Protocol docs: About Bio Protocol